Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00330486 · ClinicalTrials.gov registry record · Phase 1
Open Label Trial of Acamprosate in Bipolar Alcoholics
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT00330486 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 9 participants.
The verdict
NCT00330486, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether acamprosate (Campral) is safe and effective in treating alcohol dependence in individuals with bipolar disorder. All subjects in the study must be currently stabilized on mood-stabilizing medication. Half of the subjects will receive acamprosate in addition to their mood-stabilizing medication; control subjects will be maintained on their mood-stabilizing medication alone. Measures of alcohol use as well as mood stability will be obtained weekly throughout the active phase of the study.
Interventions
- DRUG Acamprosate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00330486
The ClinicalTrials.gov registry entry for NCT00330486 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acamprosate is the first listed.
NCT00330486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00330486 about?
NCT00330486 is a clinical study titled "Open Label Trial of Acamprosate in Bipolar Alcoholics". The purpose of this study is to determine whether acamprosate (Campral) is safe and effective in treating alcohol dependence in individuals with bipolar disorder. All subjects in the study must be currently stabilized on mood-stabilizing medication. Half of the subjects will receive acamprosate in a...
What is the current status of trial NCT00330486?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2006-04. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00330486?
The interventions under investigation include: Acamprosate (DRUG).
Who is sponsoring clinical trial NCT00330486?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.